Evidence mapPaperPMID 37828947Full record

ArticleFrontiers in medicine2023

Prevalence of chronic venous insufficiency and deep vein thrombosis in cirrhotic patients.

Leonardo da Cruz Renó, Francisco Tustumi, Daniel Reis Waisberg, Vinicious Rocha Santos, Rafael Soares Pinheiro, Rubens Arantes Macedo, Lucas Souto Nacif, Liliana Ducatti, Rodrigo Bronze De Martino, Alexandre Maximiniano Trevisan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Leonardo da Cruz RenóDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Francisco TustumiDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Daniel Reis WaisbergDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Vinicious Rocha SantosDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Rafael Soares PinheiroDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Rubens Arantes MacedoDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Lucas Souto NacifDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Liliana DucattiDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Rodrigo Bronze De MartinoDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Alexandre Maximiniano TrevisanDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Luiz Carneiro D'AlbuquerqueDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Wellington AndrausDepartment of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: People with cirrhosis of the liver are at risk for complications that can worsen their quality of life and increase morbidity and mortality. Contrary to previous beliefs, cirrhosis does not protect against the development of thromboembolic events, and cirrhotic patients may have higher rates of deep vein thrombosis (DVT). Background and aims: The study of chronic venous disease and its impact on patients with cirrhosis is unknown in the literature and may be an important fact since this condition also had impact on quality of life and morbidity. The aim of this study is to evaluate the prevalence of DVT (Deep Venous thrombosis) in outpatients with cirrhosis and the degree of chronic venous insufficiency, evaluating possible correlations between clinical and laboratory aspects of cirrhotic patients with these pathologies. Methods: Patients with cirrhosis were evaluated in the outpatient clinic of the Liver Transplantation and Hepatology Service of HC-FMUSP from November 2018 to November 2022, with clinical evaluation, venous disease questionnaires, data collection of imaging and laboratory tests, and venous color Doppler ultrasound. The information was analyzed by the University of São Paulo (USP) Statistics Department. Results: There was a prevalence of 7.6% of DVT in studied patients, VCSS score 6.73 and severe CEAP classification (C4-6) 32.1%. There was no association of DVT with qualitative variables by the Fisher test such as Child Turcotte Pugh Scale (CTP) ( Conclusion: The incidence of VTE (Venous Thromboembolic Events) and CVD (Chronic Venous Disease) within the sample surpassed that of the general population; nevertheless, more studies are required to validate these results. Concerning venous thromboembolism, no correlation was observed between the variables within the sample and the augmented risk of VTE. Regarding chronic venous disease, studies have shown that edema and orthostatism are correlated with increased severity of CVD on the VCSS scales. Statistical dispersion methods suggest that patients with higher BMI and more severe liver disease (according to the Child-Pugh score) are more likely to experience worsening of CVD. About chronic venous disease, studies have shown that edema and orthostatism are correlated with increased severity of CVD on the VCSS scales.

Indexed as

cirrhosisdeep vein thromboembolismliver diseasevenous diseasevenous incompetence

Identifiers

PMID37828947
PMCPMC10565485
OpenAlexW4387119278

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.